NCT04002596 - Safety and Initial Effectiveness of Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 6, 2017

Primary Completion Date

August 30, 2020

Study Completion Date

December 31, 2020

Conditions

Parkinson Disease

Interventions

DEVICE

ExAblate Neuro Thalamotomy Treatment

Non-invasive Focused Ultrasound Ablation of Thalamus Vim nucleus using ExAblate MRgFUS system for treatment Tremor Dominant Parkinson Disease

Trial Locations (2)

RECRUITING

Henan Provincial Peoples Hospital, Zhengzhou

RECRUITING

Shonan Fujisawa Tokushukai Hospital, Fujisawa